Product Details
Place of Origin: China
Brand Name: Sunshine
Certification: ISO,COA
Model Number: 319460-85-0
Payment & Shipping Terms
Minimum Order Quantity: Negotiation
Price: Negotiation
Packaging Details: Aluminum Foil Bag, Drum
Delivery Time: 7-15 days
Payment Terms: T/T, L/C, D/A, Western Union
Supply Ability: TON
CAS NO:: |
319460-85-0 |
Appearance:: |
Off-white Solid |
Molecular Formula:: |
C22H18N4OS |
Molecular Weight:: |
386.4700 |
EINECS NO:: |
638-771-6 |
MDL NO:: |
MFCD09837898 |
CAS NO:: |
319460-85-0 |
Appearance:: |
Off-white Solid |
Molecular Formula:: |
C22H18N4OS |
Molecular Weight:: |
386.4700 |
EINECS NO:: |
638-771-6 |
MDL NO:: |
MFCD09837898 |
Product Description:
Product Name: axitinib CAS NO: 319460-85-0
Synonyms:
[14C]-Axitinib;
Inlyta;
Axitinib (usan);
Chemical & Physical Properties:
Appearance: Off-white solid
Assay: ≥99.0%
Density: 1.35 g/cm3
Boiling Point: 668.9℃ at 760 mmHg
Melting Point: 213-215℃
Flash Point: 358.3℃
Refractive Index: 1.728
Safety Information:
Caution Statement: P273
HS Code: 2933990090
Hazard Declaration: H302; H400
Signal Word: Warning
Symbol: GHS07, GHS09
Axitinib (AG013736; trade name Inlyta) is a small molecule tyrosine kinase inhibitor developed by Pfizer. It has been shown to significantly inhibit growth of breast cancer in animal (xenograft) models and has shown partial responses in clinical trials with renal cell carcinoma (RCC) and several other tumour types.
It was approved for RCC by the U.S. Food and Drug Administration after showing a modest increase in progression-free survival, though there have been reports of fatal adverse effects.
If you are interested in our products or have any questions, please feel free to contact us!
Products under patent are offered for R & D purpose only. However, the final responsibility lies exclusively with the buyer.
